About Nasal Cannula
The nasal cannula is a device that is used to deliver when a low flow, low or medium concentration is required, and the patient is in a stable state. It is a flexible tube that is placed under the nose. It consists of two prongs that go inside the nostrils. It is widely used in oxygen therapy where small amounts of supplemental oxygen are required. It is also used to deliver high flows of an air/oxygen blend to accurately deliver high volume of oxygen therapy.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Nasal Cannula market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Westmed, Inc. (United States), Medtronic PLC (Ireland), Sorin Group (Germany), Terumo Corporation (Japan), Flexicare Medical Ltd. (United Kingdom), medin Medical Innovations GmbH (Germany), Fisher and Paykel Healthcare Ltd. (New Zealand), Salter Labs (United States), Smiths Medical, Inc. (United States) and Vapotherm Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Teleflex (United States) and Vyaire Medical, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Nasal Cannula market by Type (Curved Prong Cannula, Flared Prong Cannula, Curved and Flared Prong Cannula and Straight Prong Cannula), Application (Supplemental Oxygen and Nasal High-flow Therapy) and Region.
On the basis of geography, the market of Nasal Cannula has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Disease Type, the sub-segment i.e. Asthma will boost the Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Material, the sub-segment i.e. Plastic will boost the Nasal Cannula market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Awareness among People about Personal Health and Hygiene and Increase in the Distribution Channels
Market Growth Drivers:
Increased Prevalence of Breathing Diseases such as Asthma, Pneumonia and Cystic Fibrosis, Increased Number of Diagnostic Centres and Hospitals and High Research and Development Investment
Challenges:
Stringent Government Rules and Regulations
Restraints:
Complications Associated with Nasal Cannula and Fluctuations in the Raw Material Prices Such as Plastic
Opportunities:
Growing Healthcare Industry Worldwide, Rise in the E-commerce Industry and Increased Government Funding for Healthcare Industry
Market Leaders and their expansionary development strategies
In November 2019, Terumo Corporation has announced that it has decided to acquire Aortica Corporation, a U.S.-based company dedicated to advancing the science of personalised vascular therapy.
In May 2020, Medtronic plc MDT recently launched a new type of Cannula for balloon kyphoplasty surgeries in the United States. This Kyphon Assist Directional Cannula will be used together with the company’s balloon kyphoplasty (BKP) products to treat vertebral compression fractures that may occur due to osteoporosis, cancer or benign lesions.
Key Target Audience
Nasal Cannula Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies and End-users
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.